Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Adaptate Biotherapeutics
company
About
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ.
- London,Ontario,Canada
- 11 - 50
- https://www.adaptate.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- £13M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Adaptate Biotherapeutics Ltd.
- Also Known As
- Adaptate
Adaptate is a biotherapeutics company that develops antibodies to modulate gamma delta T cells in situ. The company was founded in 2019 by Adrian Hayday and is headquartered in London.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£13M
Adaptate Biotherapeutics has raised a total of
£13M
in funding over 2 rounds. Their latest funding was raised on
Apr 19, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 19, 2021 | Series A | £13M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Adaptate Biotherapeutics is funded by 2 investors.
Abingworth
and Takeda Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Abingworth
|
— | Series A |
Takeda Ventures
|
— | Series A |
Employee Profiles
Number of Employee Profiles
3
Adaptate Biotherapeutics has 3 current employee profiles, including
Executive Natalie Mount
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
